Phenotypes and WBC of HSC/HPC-derived tumors
Oncogene . | DP . | DN . | SP . | CD19 . | CD11b . | WBC more than 15 × 109/L . |
---|---|---|---|---|---|---|
LMO2, n = 12 | 10/12 | 1/12 | 1/12 | 0/12 | 0/12 | 7/8 |
TCL1, n = 10 | 2/9 | 0/9 | 3/9 | 4/9 | 0/9 | 5/7 |
ΔTrkAhigh, n = 12 | 4/9 | 0/9 | 0/9 | 0/9 | 5/9 | 2/2 |
ΔTrkAlow, n = 9 | 9/9 | 0/9 | 0/9 | 0/9 | 0/9 | 6/7 |
Oncogene . | DP . | DN . | SP . | CD19 . | CD11b . | WBC more than 15 × 109/L . |
---|---|---|---|---|---|---|
LMO2, n = 12 | 10/12 | 1/12 | 1/12 | 0/12 | 0/12 | 7/8 |
TCL1, n = 10 | 2/9 | 0/9 | 3/9 | 4/9 | 0/9 | 5/7 |
ΔTrkAhigh, n = 12 | 4/9 | 0/9 | 0/9 | 0/9 | 5/9 | 2/2 |
ΔTrkAlow, n = 9 | 9/9 | 0/9 | 0/9 | 0/9 | 0/9 | 6/7 |
Data are phenotypes per group size. For some animals, the phenotype or WBC was not determined. Additional tables can be found in Table S1.
DP indicates double-positive; DN, double-negative; SP, single-positive for T-cell markers CD4 and CD8; and n, number of animals for each oncogene.